281
Views
31
CrossRef citations to date
0
Altmetric
Original

Methamphetamine Users in the Psychiatric Emergency Services: A Case-Control Study

, M.D., Ph.D., , Ph.D., , M.D. & , M.D.
Pages 675-686 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Njabulo Churchill Sibanda$suffix/text()$suffix/text(), Rachel Kornhaber$suffix/text()$suffix/text(), Glenn E. Hunt$suffix/text()$suffix/text(), Kirsten Morley$suffix/text()$suffix/text() & Michelle Cleary$suffix/text()$suffix/text(). (2019) Prevalence and Risk Factors of Emergency Department Presentations with Methamphetamine Intoxication or Dependence: A Systematic Review and Meta-analysis. Issues in Mental Health Nursing 40:7, pages 567-578.
Read now

Articles from other publishers (30)

Alma Rahimi, Nicole Kozloff, Albert H.C. Wong & Kristina M. Gicas. (2023) Clinical Characterization of Methamphetamine-related Emergency Department Use in a Canadian Psychiatric Hospital. Canadian Journal of Addiction 14:4, pages 30-35.
Crossref
Julie Nguyen, Stephen Lee, Dennis Ankrah & Erin Knox. (2022) Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis. Mental Health Clinician 12:1, pages 9-14.
Crossref
Jagoda Pasic & Margaret A. Cashman. 2021. Behavioral Emergencies for Healthcare Providers. Behavioral Emergencies for Healthcare Providers 59 74 .
Charles E. MurphyIVIV, Ralph C. Wang, Zlatan Coralic, Andrew R. Lai & Maria Raven. (2020) Association Between Methamphetamine Use and Psychiatric Hospitalization, Chemical Restraint, and Emergency Department Length of Stay. Academic Emergency Medicine 27:11, pages 1116-1125.
Crossref
Sarah Baker & David Castle. (2020) The Cardiac Conduction and Contractility Complications of Methamphetamine Use and the Relationship to Psychiatric Comorbidity: A Systematic Review. Current Psychiatry Research and Reviews 16:1, pages 5-19.
Crossref
Jeremy Miller, Robby Atala, Dusadee Sarangarm, Mauricio Tohen, Shiva Sharma, Snehal Bhatt, Mohamad Khafaja, Phillip J. Kroth & Mario Cruz. (2020) Methamphetamine Abuse Trends in Psychiatric Emergency Services: A Retrospective Analysis Using Big Data. Community Mental Health Journal 56:5, pages 959-962.
Crossref
Rikki Jones, Cindy Woods, Ruth Barker & Kim Usher. (2019) Patterns and features of methamphetamine‐related presentations to emergency departments in QLD from 2005 to 2017. International Journal of Mental Health Nursing 28:4, pages 833-844.
Crossref
Ahmad Hajebi, Homayoun Amini, Leila Kashani & Vandad Sharifi. (2016) Twelve‐month course and outcome of methamphetamine‐induced psychosis compared with first episode primary psychotic disorders. Early Intervention in Psychiatry 12:5, pages 928-934.
Crossref
Rikki Jones, Cindy Woods & Kim Usher. (2018) Rates and features of methamphetamine‐related presentations to emergency departments: An integrative literature review. Journal of Clinical Nursing 27:13-14, pages 2569-2582.
Crossref
Rebecca McKetin, Louisa Degenhardt, Marian Shanahan, Amanda L. Baker, Nicole K. Lee & Dan I. Lubman. (2017) Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact. Drug and Alcohol Review 37:2, pages 196-204.
Crossref
Xiaobin Xue, Yun Song, Xiaojie Yu, Qiang Fan, Jiyou Tang & Xu Chen. (2018) Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants. Medicine 97:8, pages e9786.
Crossref
Justin C. Strickland & William W. Stoops. 2018. Adolescent Substance Abuse. Adolescent Substance Abuse 233 260 .
Anna R. Reynolds, Justin C. Strickland, William W. Stoops, Joshua A. Lile & Craig R. Rush. (2017) Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. Drug and Alcohol Dependence 181, pages 25-29.
Crossref
Kim Usher, Debra Jackson, Cindy Woods, Jan Sayers, Rachel Kornhaber & Michelle Cleary. (2017) Safety, risk, and aggression: Health professionals’ experiences of caring for people affected by methamphetamine when presenting for emergency care. International Journal of Mental Health Nursing 26:5, pages 437-444.
Crossref
Celene Y. L. Yap, David McD Taylor, Jonathan C. Knott, Simone E. Taylor, Georgina A. Phillips, Jonathan Karro, Esther W. Chan, David C. M. Kong & David J. Castle. (2017) Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial. Addiction 112:7, pages 1262-1269.
Crossref
Homa Zarrabi, Mohammadrasoul Khalkhali, Azam Hamidi, Reza Ahmadi & Maryam Zavarmousavi. (2016) Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients. BMC Psychiatry 16:1.
Crossref
Erika Pike, William W. Stoops & Craig R. Rush. (2016) Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine. Pharmacology Biochemistry and Behavior 150-151, pages 87-93.
Crossref
Catherine Fassbender, Tyler A. Lesh, Stefan Ursu & Ruth Salo. (2015) Reaction Time Variability and Related Brain Activity in Methamphetamine Psychosis. Biological Psychiatry 77:5, pages 465-474.
Crossref
Ruth Salo, Catherine Fassbender, Ana-Maria Iosif, Stefan Ursu, Martin H Leamon & Cameron Carter. (2013) Predictors of methamphetamine psychosis: History of ADHD-relevant childhood behaviors and drug exposure. Psychiatry Research 210:2, pages 529-535.
Crossref
Robert L. Cloutier, Robert G. Hendrickson, Rongwei (Rochelle) Fu & Brian Blake. (2013) Methamphetamine-related Psychiatric Visits to an Urban Academic Emergency Department: An Observational Study. The Journal of Emergency Medicine 45:1, pages 136-142.
Crossref
Jagoda Pasic & Margaret Cashman. 2013. Behavioral Emergencies for the Emergency Physician. Behavioral Emergencies for the Emergency Physician 36 45 .
. 2013. Behavioral Emergencies for the Emergency Physician. Behavioral Emergencies for the Emergency Physician 19 52 .
Sigrid Medhus, Jon Mordal, Bjørn Holm, Jørg Mørland & Jørgen G. Bramness. (2013) A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Research 206:1, pages 17-21.
Crossref
Adam C. Pomerleau, Mark E. Sutter, Kelly P. Owen, Eleanor Loomis, Timothy E. Albertson & Deborah B. Diercks. (2012) Amphetamine Abuse in Emergency Department Patients Undergoing Psychiatric Evaluation. The Journal of Emergency Medicine 43:5, pages 798-802.
Crossref
David Vearrier, Michael I. Greenberg, Susan Ney Miller, Jolene T. Okaneku & David A. Haggerty. (2012) Methamphetamine: History, Pathophysiology, Adverse Health Effects, Current Trends, and Hazards Associated with the Clandestine Manufacture of Methamphetamine. Disease-a-Month 58:2, pages 38-89.
Crossref
Craig R. Rush, William W. Stoops, Joshua A. Lile, Paul E.A. Glaser & Lon R. Hays. (2011) Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacology Biochemistry and Behavior 100:1, pages 40-47.
Crossref
Rajkumar J. Sevak, Andrea R. Vansickel, William W. Stoops, Paul E.A. Glaser, Lon R. Hays & Craig R. Rush. (2011) Discriminative-Stimulus, Subject-Rated, and Physiological Effects of Methamphetamine in Humans Pretreated With Aripiprazole. Journal of Clinical Psychopharmacology 31:4, pages 470-480.
Crossref
Craig R. Rush, William W. Stoops, Joshua A. Lile, Paul E. A. Glaser & Lon R. Hays. (2010) Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology 214:3, pages 665-674.
Crossref
JAMES SHEARER, MARIAN SHANAHAN, SHANE DARKE, CRAIG RODGERS, INGRID VAN BEEK, REBECCA MCKETIN & RICHARD P. MATTICK. (2010) A cost‐effectiveness analysis of modafinil therapy for psychostimulant dependence. Drug and Alcohol Review 29:3, pages 235-242.
Crossref
Steven J Shoptaw, Uyen Kao, Keith Heinzerling & Walter Ling. (2009) Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.